BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8619420)

  • 1. Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen.
    Kitamura H; Kameda Y; Nakamura N; Inayama Y; Nakatani Y; Shibagaki T; Ito T; Hayashi H; Kimura H; Kanisawa M
    Am J Surg Pathol; 1996 May; 20(5):553-62. PubMed ID: 8619420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.
    Kitamura H; Kameda Y; Nakamura N; Nakatani Y; Inayama Y; Iida M; Noda K; Ogawa N; Shibagaki T; Kanisawa M
    Am J Pathol; 1995 Apr; 146(4):876-87. PubMed ID: 7717455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin expression in atypical adenomatous hyperplasia of the lung.
    Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E
    Am J Clin Pathol; 2003 Nov; 120(5):712-9. PubMed ID: 14608897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytodifferentiation of atypical adenomatous hyperplasia and bronchioloalveolar lung carcinoma: immunohistochemical and ultrastructural studies.
    Kitamura H; Kameda Y; Ito T; Hayashi H; Nakamura N; Nakatani Y; Inayama Y; Kanisawa M
    Virchows Arch; 1997 Dec; 431(6):415-24. PubMed ID: 9428929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung.
    Yamasaki M; Takeshima Y; Fujii S; Kitaguchi S; Matsuura M; Tagawa K; Inai K
    Pathol Int; 2000 Oct; 50(10):778-85. PubMed ID: 11107049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of B72.3, carcinoembryonic antigen, and Leu M-1 in cell blocks: an adjunct to fine-needle aspiration diagnosis of bronchioloalveolar carcinoma of the lung.
    Chandan VS; Truong LD; Khurana KK
    Cancer; 2005 Aug; 105(4):246-52. PubMed ID: 15971208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
    Awaya H; Takeshima Y; Yamasaki M; Inai K
    Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchioloalveolar carcinoma: diagnostic pitfalls and immunocytochemical contribution.
    Saleh HA; Haapaniemi J; Khatib G; Sakr W
    Diagn Cytopathol; 1998 Apr; 18(4):301-6. PubMed ID: 9557268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
    Seki N; Takasu T; Mandai K; Nakata M; Saeki H; Heike Y; Takata I; Segawa Y; Hanafusa T; Eguchi K
    Clin Cancer Res; 2002 Oct; 8(10):3046-53. PubMed ID: 12374671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonality of atypical adenomatous hyperplasia of the lung.
    Niho S; Yokose T; Suzuki K; Kodama T; Nishiwaki Y; Mukai K
    Am J Pathol; 1999 Jan; 154(1):249-54. PubMed ID: 9916939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis.
    Mori M; Chiba R; Takahashi T
    Cancer; 1993 Oct; 72(8):2331-40. PubMed ID: 8402446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of XIAP and p63 in adenomatous hyperplasia, atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and well-differentiated adenocarcinoma.
    Wu M; Orta L; Gil J; Li G; Hu A; Burstein DE
    Mod Pathol; 2008 May; 21(5):553-8. PubMed ID: 18432259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia.
    Koga T; Hashimoto S; Sugio K; Yonemitsu Y; Nakashima Y; Yoshino I; Matsuo Y; Mojtahedzadeh S; Sugimachi K; Sueishi K
    Am J Clin Pathol; 2002 Mar; 117(3):464-70. PubMed ID: 11888087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity.
    Ohtsuka T; Watanabe K; Kaji M; Naruke T; Suemasu K
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):160-3. PubMed ID: 16723239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
    J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
    Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
    Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Nakanishi K; Matsuo H; Kanai Y; Endou H; Hiroi S; Tominaga S; Mukai M; Ikeda E; Ozeki Y; Aida S; Kawai T
    Virchows Arch; 2006 Feb; 448(2):142-50. PubMed ID: 16175382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
    Kohno T; Kakinuma R; Iwasaki M; Yamaji T; Kunitoh H; Suzuki K; Shimada Y; Shiraishi K; Kasuga Y; Hamada GS; Furuta K; Tsuta K; Sakamoto H; Kuchiba A; Yamamoto S; Kanai Y; Tsugane S; Yokota J
    Carcinogenesis; 2010 Oct; 31(10):1794-9. PubMed ID: 20688833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.